BrainCool AB stock analysis
BrainCool AB (0G85) Share Price & Analysis
0G85 Stock Chart & Stats
- Day’s Range
- SEK 1.82 - SEK 1.82
- 52-Week Range
- SEK 1.82 - SEK 1.82
- Previous Close
- SEK 1.82
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- SEK 429.63M
- Enterprise Value
- SEK 390.19M
- Total Cash (Recent Filing)
- SEK 43.09M
- Total Debt (Recent Filing)
- SEK 0
- Price to Earnings (P/E)
- ―
- Beta
- 0.00
- Next Earnings
- Feb 17, 2027 (Est.)
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Improving Revenue Growth
Improving TTM revenue indicates that BrainCool is gaining commercial traction in temperature-management therapies. If this trend persists, expanding hospital adoption can support greater device utilization, increase consumables demand, and provide a foundation for future operating leverage.
Debt-Free Balance Sheet
A debt-free, conservatively financed balance sheet reduces leverage and refinancing risk while preserving flexibility to fund product development and commercialization. The sizable equity cushion provides greater resilience as BrainCool works to improve profitability and scale its operations.
Recurring Consumables Revenue Model
The installed-base model can create recurring revenue beyond the initial equipment sale because each treatment may require single-use consumables. As adoption expands across hospitals, this structure can deepen customer relationships, improve revenue visibility, and support longer-term commercial scalability.
Bears Say
Persistent Unprofitability
Persistent negative gross profit and operating losses show that BrainCool has not yet established a stable, scalable profit model. Continued unprofitability may restrict internal funding capacity and makes future earnings improvement dependent on stronger economics from sales growth and cost control.
Significant Cash Burn
Substantial negative operating and free cash flow means reported losses are translating into real cash outflows, increasing the resources required to sustain operations. If cash generation does not improve, BrainCool may need to reduce investment or seek additional funding to continue its growth plans.
Equity Erosion Risk
Negative returns on the equity base indicate that shareholder capital is not currently generating positive economic returns. If losses continue, the equity cushion can erode over time and the company may face greater pressure to preserve liquidity, improve margins, or raise capital.
BrainCool AB News
0G85 FAQ
What was BrainCool AB’s price range in the past 12 months?
What is BrainCool AB’s market cap?
When is BrainCool AB’s upcoming earnings report date?
How were BrainCool AB’s earnings last quarter?
Is BrainCool AB overvalued?
Does BrainCool AB pay dividends?
What is BrainCool AB’s EPS estimate?
How many shares outstanding does BrainCool AB have?
What happened to BrainCool AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of BrainCool AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
BrainCool AB
BrainCool AB (publ), a medical technology company founded in 2010 and headquartered in Lund, Sweden, focuses on the development, commercialization, and distribution of advanced medical cooling systems. Operating with its subsidiaries, the company caters to the healthcare sector, primarily serving the Swedish market, by providing innovative solutions for various conditions including stroke, sudden cardiac arrest, oral mucositis, and migraine. Their product line features the BrainCool and RhinoChill systems, specifically engineered to deliver swift therapeutic cooling in emergency situations, thereby ensuring uninterrupted patient care. To mitigate the risk of oral mucositis, BrainCool offers the Cooral system, renowned for its user-friendly design for medical professionals. Furthermore, the IQool system boasts an intuitive interface complemented by informative graphics and an automatic feedback loop, empowering clinicians to dedicate their attention to patient management rather than device operation.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Anna Lindstrom
- Employees
- 15
- Website
- www.braincool.se
- Address
- Medicon Village, Lund, SN, 223 81, SE
BrainCool AB (0G85) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 1 | 10 |
| Technical Analysis | 0 | 1 | 2 |
| Moving Averages | 4 | 0 | 8 |





